Gene · 8564
Papers1,472
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 1,472
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Role for Xanthurenic Acid in the Control of Brain Dopaminergic Activity. | Int J Mol Sci | 2021 | 34203531 | PubTator, text mining | PubMed |
| The Comprehensive "Omics" Approach from Metabolomics to Advanced Omics for Development of Immune Checkpoint Inhibitors: Potential Strategies for Next Generation of Cancer Immunotherapy. | Int J Mol Sci | 2021 | 34203237 | PubTator, text mining | PubMed |
| Immune Influencers in Action: Metabolites and Enzymes of the Tryptophan-Kynurenine Metabolic Pathway. | Biomedicines | 2021 | 34202246 | PubTator, text mining | PubMed |
| Kynurenines as a Novel Target for the Treatment of Malignancies. | Pharmaceuticals (Basel) | 2021 | 34201791 | PubTator, text mining | PubMed |
| The Footprint of Kynurenine Pathway in Neurodegeneration: Janus-Faced Role in Parkinson's Disorder and Therapeutic Implications. | Int J Mol Sci | 2021 | 34201647 | PubTator, text mining | PubMed |
| Crosstalk between Tryptophan Metabolism via Kynurenine Pathway and Carbohydrate Metabolism in the Context of Cardio-Metabolic Risk-Review. | J Clin Med | 2021 | 34199713 | PubTator, text mining | PubMed |
| Neurodegeneration in Multiple Sclerosis: Symptoms of Silent Progression, Biomarkers and Neuroprotective Therapy-Kynurenines Are Important Players. | Molecules | 2021 | 34198750 | PubTator, text mining | PubMed |
| Genetic Analysis of Tryptophan Metabolism Genes in Sporadic Amyotrophic Lateral Sclerosis. | Front Immunol | 2021 | 34194442 | PubTator, text mining | PubMed |
| Identification of hub genes associated with prognosis, diagnosis, immune infiltration and therapeutic drug in liver cancer by integrated analysis. | Hum Genomics | 2021 | 34187556 | PubTator, text mining | PubMed |
| 3-Hydroxykynurenine Regulates Lipopolysaccharide-Stimulated IL-6 Production and Protects against Endotoxic Shock in Mice. | Immunohorizons | 2021 | 34183381 | PubTator, text mining | PubMed |
| Ketamine's effect on inflammation and kynurenine pathway in depression: A systematic review. | J Psychopharmacol | 2021 | 34180293 | PubTator, text mining | PubMed |
| Identification ACTA2 and KDR as key proteins for prognosis of PD-1/PD-L1 blockade therapy in melanoma. | Animal Model Exp Med | 2021 | 34179721 | PubTator, text mining | PubMed |
| Amino Acid Trp: The Far Out Impacts of Host and Commensal Tryptophan Metabolism. | Front Immunol | 2021 | 34149693 | PubTator, text mining | PubMed |
| Tryptophan-kynurenine metabolism: a link between the gut and brain for depression in inflammatory bowel disease. | J Neuroinflammation | 2021 | 34127024 | PubTator, text mining | PubMed |
| Oral Administration of Brain Protein Combined With Probiotics Induces Immune Tolerance Through the Tryptophan Pathway. | Front Mol Neurosci | 2021 | 34122006 | PubTator, text mining | PubMed |
| Kynurenines and Neurofilament Light Chain in Multiple Sclerosis. | Front Neurosci | 2021 | 34113231 | PubTator, text mining | PubMed |
| TDO2 overexpression correlates with poor prognosis, cancer stemness, and resistance to cetuximab in bladder cancer. | Cancer Rep (Hoboken) | 2021 | 34101386 | PubTator, text mining | PubMed |
| Capillary electrochromatography-mass spectrometry of kynurenine pathway metabolites. | J Chromatogr A | 2021 | 34098249 | PubTator, text mining | PubMed |
| NAD+ Metabolism, Metabolic Stress, and Infection. | Front Mol Biosci | 2021 | 34095234 | PubTator, text mining | PubMed |
| Targeting Amino Acid Metabolic Vulnerabilities in Myeloid Malignancies. | Front Oncol | 2021 | 34094976 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8564/papers?page=31